Narrative Review of Anomalous Origin of Coronary Arteries: Pathophysiology, Management, and Treatment

被引:2
作者
Kanagala, Sai Gautham [1 ]
Gupta, Vasu [2 ]
Dunn, Garrett, V [3 ]
Kaur, Harmanjit [4 ]
Zieneddine, Farid [5 ]
Jain, Rohit [6 ]
Garg, Nikita [7 ]
机构
[1] Osmania Med Coll & Hosp, Hyderabad 500095, Telangana, India
[2] Dayanand Med Coll & Hosp, Ludhiana, India
[3] Penn State Coll Med, Hershey, PA 17033 USA
[4] Govt Med Coll, Patiala, India
[5] Penn State Milton S Hershey Med Ctr, Dept Internal Med, Hershey, PA 17033 USA
[6] Penn State Hlth Milton S Hershey Med Ctr, Hershey, PA USA
[7] SIU Sch Med, Dept Pediat, Springfield, IL USA
关键词
Coronary artery anomalies; sudden cardiac death; left aortic sinus; right coronary sinus; the anomalous aortic origin of the coronary artery; anomalous coronary arteries from the pulmonary artery; AORTIC ORIGIN;
D O I
10.2174/1573403X19666230530095341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary artery anomalies (CAA) are a diverse group of congenital anomalies and are the second most common cause of sudden cardiac death in the young population after Hypertrophic Cardiomyopathy (HCM). Symptoms range from chest pain, syncope, or sudden cardiac arrest to completely asymptomatic. The prevalence of congenital coronary artery anomalies in the general population is estimated to be between 1% and 2%. CAA often gets underdiagnosed due to the lack of knowledge of the disease process. Approximately 5% of patients with acute myocardial infarction do not have atherosclerotic coronary artery disease or luminal narrowing due to other causes. Congenital coronary artery anomalies account for 50-60% of this 5% of patients. Most patients are asymptomatic for most of their lives, and chest pain is the most common symptom in symptomatic patients when referred for coronary angiography, typically when the diagnosis is typically made. The malignant coronary artery is a rare presentation of a coronary anomaly when associated with atherosclerotic coronary artery disease or valvular heart disease. Patients with symptoms of an abnormal coronary artery origin will receive medical treatment/observation, exercise restriction, coronary angioplasty with stent deployment, or surgical repair.
引用
收藏
页数:6
相关论文
共 33 条
[1]   Adult Anomalous Left Coronary Artery Arising From the Pulmonary Artery (ALCAPA) Syndrome as First Presentation With Atrial Fibrillation in a Marathon Runner [J].
Alsamman, Mrhaf ;
Tuna, Kubra ;
Dunn, Sandi ;
Rifai, Faysal ;
Reed, Justin .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
[2]   Anomalous Aortic Origin of a Coronary Artery with an Interarterial Course: Understanding Current Management Strategies in Children and Young Adults [J].
Brothers, Julie ;
Gaynor, J. William ;
Paridon, Stephen ;
Lorber, Richard ;
Jacobs, Marshall .
PEDIATRIC CARDIOLOGY, 2009, 30 (07) :911-921
[3]   Expert consensus guidelines: Anomalous aortic origin of a coronary artery [J].
Brothers, Julie A. ;
Frommelt, Michele A. ;
Jaquiss, Robert D. B. ;
Myerburg, Robert J. ;
Fraser, Charles D., Jr. ;
Tweddell, James S. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (06) :1440-1457
[4]   Anomalous aortic origin of a coronary artery with an interarterial course [J].
Brothers, Julie A. ;
Stephens, Paul ;
Gaynor, J. William ;
Lorber, Richard ;
Vricella, Luca A. ;
Paridon, Stephen M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (21) :2062-2064
[5]  
Carboni Gian Piero, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.02.2012.5884
[6]  
Collet JP, 2021, REV ESP CARDIOL, V74, DOI [10.1016/j.rec.2021.05.002, 10.1093/eurheartj/ehaa575]
[7]  
Doan TT, 2020, J INVASIVE CARDIOL, V32, P176
[8]   Anomalous origin of coronary arteries from pulmonary artery in adults: a case series [J].
Eduardo Vergara-Uzcategui, Carlos ;
das Neves, Barbara ;
Salinas, Pablo ;
Fernandez-Ortiz, Antonio ;
Nunez-Gil, Ivan J. .
EUROPEAN HEART JOURNAL-CASE REPORTS, 2020, 4 (02)
[9]   Coronary Artery Anomalies [J].
Gentile, Francesco ;
Castiglione, Vincenzo ;
De Caterinao, Raffaele .
CIRCULATION, 2021, 144 (12) :983-996
[10]  
Grani Christoph, 2019, Interv Cardiol, V14, P83, DOI 10.15420/icr.2019.1.1